Foundation Medicine is a global precision medicine company, founded in 2010, that develops comprehensive genomic profiling diagnostics for cancer and other diseases. Its technical work spans genomics, molecular diagnostics, liquid biopsy, companion diagnostics and the maintenance of a genomic database used for research. The company operates in the United States and globally, and works with patients, physicians, researchers and biopharmaceutical organisations.
Its product line comprises three FDA-approved tests. FoundationOne CDx is a tissue-based companion diagnostic covering all solid tumours and more than 35 targeted therapy indications. FoundationOne Liquid CDx is a blood-based companion diagnostic covering more than 15 targeted therapies. FoundationOne Heme is a genomic profiling test for haematologic malignancies. All are covered by major U.S. health insurers.
The company describes itself as patient-focused and positions its work as spanning oncology, precision medicine, molecular diagnostics and pharmaceutical research and development. It states a mission of transforming lives in cancer and beyond.
